What Makes Verona Pharma plc (VRNA) a Good Investment? - Yahoo Finance
4 days ago • Google News
Verona Pharma PLC ADR (VRNA)
US$ 63.32-4.44%
Price Chart
Key Statistics
Market Cap
$ 9B
P/E Ratio
0.00
Revenue (TTM)
$ 118.54M
Volume
1.93M
52W High
$ 74.18
52W Low
$ 11.39
Dividend Yield
0.00%
Beta
0.20
Technicals
50-Day MA
63.89
200-Day MA
45.0528
52 Week High
74.18
52 Week Low
11.39
About VRNA
Verona Pharma plc, a biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company offers Ohtuvay.
Employees
209
Headquarters
London, United Kingdom
CEO
Dr. David S. Zaccardelli Pharm.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg